Matinas BioPharma (NYSEAMERICAN:MTNB) Announces Earnings Results

Matinas BioPharma (NYSEAMERICAN:MTNB) announced its quarterly earnings data on Wednesday. The company reported ($0.03) EPS for the quarter, Yahoo Finance reports.

Matinas BioPharma Stock Performance

NYSEAMERICAN MTNB opened at $0.27 on Friday. Matinas BioPharma has a 52 week low of $0.11 and a 52 week high of $0.89.

Institutional Trading of Matinas BioPharma

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of Matinas BioPharma by 6.4% in the 4th quarter. Vanguard Group Inc. now owns 9,317,838 shares of the company’s stock valued at $2,015,000 after buying an additional 564,020 shares in the last quarter. BlackRock Inc. grew its position in Matinas BioPharma by 0.7% in the 1st quarter. BlackRock Inc. now owns 4,325,053 shares of the company’s stock valued at $3,479,000 after buying an additional 29,643 shares during the last quarter. Geode Capital Management LLC lifted its position in Matinas BioPharma by 8.5% in the second quarter. Geode Capital Management LLC now owns 1,958,952 shares of the company’s stock valued at $705,000 after purchasing an additional 154,094 shares during the period. Jacobs Levy Equity Management Inc. purchased a new position in shares of Matinas BioPharma during the 3rd quarter worth approximately $98,000. Finally, State Street Corp grew its holdings in Matinas BioPharma by 8.0% during the first quarter. State Street Corp now owns 712,471 shares of the company’s stock worth $573,000 after acquiring an additional 52,897 shares during the period. 11.77% of the stock is currently owned by institutional investors and hedge funds.

About Matinas BioPharma

Matinas BioPharma Holdings, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.